LI
EBS icon

LMCG Investments’s Emergent Biosolutions EBS Stock Holding History

LMCG Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$294K Buy
10,305
+910
+10% +$30K 0.01% 505
2015
Q2 		$310K Sell
9,395
-4,948
-34% -$153K 0.01% 499
2015
Q1 		$413K Buy
14,343
+6,286
+78% +$180K 0.01% 486
2014
Q4 		$219K Buy
+8,057
New +$192K ﹤0.01% 507

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LMCG Investments's EBS Position: Q3 2015 in Review

LMCG Investments increased its Emergent Biosolutions (EBS) stake by 9.7% in Q3 2015, buying an estimated $30K and bringing the position to 10,305 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #505.

LMCG Investments first reported a position in EBS in Q4 2014 and has held it in 4 quarters since. The position peaked at $413K in Q1 2015. 199 funds tracked by Wall St. Rank hold EBS as of Q3 2015.

  • LMCG Investments held 10,305 shares of Emergent Biosolutions worth $294K as of Q3 2015.
  • LMCG Investments bought 910 Emergent Biosolutions shares in Q3 2015, an estimated $30K.
  • Emergent Biosolutions made up 0.01% of LMCG Investments's portfolio in Q3 2015, its #505 holding.
  • LMCG Investments first reported a position in Emergent Biosolutions in Q4 2014 and has held it in 4 quarters since.
  • LMCG Investments's Emergent Biosolutions position peaked at $413K in Q1 2015.
  • 199 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.